Severe Psoriasis
Immunology
Prevalence
3000.0 / 100K
Incidence
78.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| acitretin | Mylan II B.V. (MYL) |
Frequently asked questions
How many drugs are in development for Severe Psoriasis?
BioSniper tracks 1 drug in development for Severe Psoriasis across 1 company.
How many clinical trials target Severe Psoriasis?
There are 1 clinical trial targeting Severe Psoriasis tracked by BioSniper.
What is the prevalence of Severe Psoriasis?
The estimated prevalence of Severe Psoriasis is approximately 3000.0 per 100,000 population.
Deep-dive into Severe Psoriasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis